Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.

Reversal of established liver fibrosis by IC-2-engineered mesenchymal stem cell sheets

Open access

Abstract

Chronic hepatitis viral infection, alcoholic intoxication, and obesity cause liver fibrosis, which progresses to decompensated liver cirrhosis, a disease for which medical demands cannot be met. Since there are currently no approved anti-fibrotic therapies for established liver fibrosis, the development of novel modalities is required to improve patient prognosis. In this study, we clarified the anti-fibrotic effects of cell sheets produced from human bone marrow-derived mesenchymal stem cells (MSCs) incubated on a temperature-sensitive culture dish with the chemical compound IC-2. Orthotopic transplantation of IC-2-engineered MSC sheets (IC-2 sheets) remarkably reduced liver fibrosis induced by chronic CCl 4 administration. Further, the marked production of fibrolytic enzymes such as matrix metalloproteinase (MMP)-1 and MMP-14, as well as thioredoxin, which suppresses hepatic stellate cell activation, was observed in IC-2 sheets. Moreover, the anti-fibrotic effect of IC-2 sheets was much better than that of MSC sheets. Finally, knockdown experiments revealed that MMP-14 was primarily responsible for the reduction of liver fibrosis. Here, we show that IC-2 sheets could be a promising therapeutic option for established liver fibrosis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-019-43298-0

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Suppression of hepatic fibrosis by IC-2 sheets on the ninth day after transplantation. (A) Protocol of the animal experiment. Abbreviations: p.o., per os; Tx, transplantation. “p.o.” indicates oral administration of CCl4. “Tx” indicates transplantation of cell sheets. (B) Micrographs of liver sections subjected to Azan staining (upper), Sirius red staining (middle), and immunohistochemistry for type I collagen (lower). MSC, mesenchymal stem cell. (C) The proportions of fibrotic areas among the groups (n = 7–9 except for n = 3 for CCl4(−) group). CCl4(−) indicates control mice without CCl4 intoxication. (D) Hydroxyproline contents in the liver (n = 6 except for n = 3 for CCl4(−) group). (E) Western blot of type I collagen in recipient liver tissues. The results are expressed as the mean ± S.E.M. Levels of significance: *P < 0.05; **P < 0.01 (one-way ANOVA followed by Games–Howell test).
Figure 1 Suppression of hepatic fibrosis by IC-2 sheets on the ninth day after transplantation. (A) Protocol of the animal experiment. Abbreviations: p.o., per os; Tx, transplantation. “p.o.” indicates oral administration of CCl4. “Tx” indicates transplantation of cell sheets. (B) Micrographs of liver sections subjected to Azan staining (upper), Sirius red staining (middle), and immunohistochemistry for type I collagen (lower). MSC, mesenchymal stem cell. (C) The proportions of fibrotic areas among the groups (n = 7–9 except for n = 3 for CCl4(−) group). CCl4(−) indicates control mice without CCl4 intoxication. (D) Hydroxyproline contents in the liver (n = 6 except for n = 3 for CCl4(−) group). (E) Western blot of type I collagen in recipient liver tissues. The results are expressed as the mean ± S.E.M. Levels of significance: *P < 0.05; **P < 0.01 (one-way ANOVA followed by Games–Howell test).CC BY · PubMed Central
Figure 2 Reduction of hepatic stellate cell activation by IC-2 sheets. (A) Immunohistochemistry for alpha-smooth muscle actin (α-SMA) in recipient livers (left). Quantification of α-SMA-positive areas (right; n = 7–9 except for n = 3 for CCl4(−) group; CCl4(−) indicates control mice without CCl4 intoxication; mean ± S.E.M., *P < 0.05, **P < 0.01, one-way ANOVA, Games–Howell test). MSC, mesenchymal stem cell. (B) α-SMA expression in the recipient livers was measured by western blotting and (C) α-SMA expression in the recipient liver was measured by qRT-PCR analysis (n = 6 except for n = 3 for CCl4(−) group; mean ± S.E.M., *P < 0.05, one-way ANOVA, Games–Howell test). (D) qRT-PCR analysis of α-SMA in LX-2 cells after treatment with each secretome harvested from untreated, vehicle-treated, or IC-2-treated MSCs (n = 3, mean ± S.E.M., *P < 0.05, **P < 0.01, one-way ANOVA, least significant difference test). (E) MFGE-8 expression in MSCs on day 7 in vitro (n = 3, mean ± S.D., **P < 0.01, Student’s t-test). (F) MFGE8 and thioredoxin (TRX) expression in cell lysates (left) and secretomes (right), as analyzed by western blotting. GAPDH and Ponceau S were used as a loading control. (G) The secretion of TRX was determined by ELISA (n = 3, mean ± S.D., **P < 0.01, one-way ANOVA, least significant difference test).
Figure 2 Reduction of hepatic stellate cell activation by IC-2 sheets. (A) Immunohistochemistry for alpha-smooth muscle actin (α-SMA) in recipient livers (left). Quantification of α-SMA-positive areas (right; n = 7–9 except for n = 3 for CCl4(−) group; CCl4(−) indicates control mice without CCl4 intoxication; mean ± S.E.M., *P < 0.05, **P < 0.01, one-way ANOVA, Games–Howell test). MSC, mesenchymal stem cell. (B) α-SMA expression in the recipient livers was measured by western blotting and (C) α-SMA expression in the recipient liver was measured by qRT-PCR analysis (n = 6 except for n = 3 for CCl4(−) group; mean ± S.E.M., *P < 0.05, one-way ANOVA, Games–Howell test). (D) qRT-PCR analysis of α-SMA in LX-2 cells after treatment with each secretome harvested from untreated, vehicle-treated, or IC-2-treated MSCs (n = 3, mean ± S.E.M., *P < 0.05, **P < 0.01, one-way ANOVA, least significant difference test). (E) MFGE-8 expression in MSCs on day 7 in vitro (n = 3, mean ± S.D., **P < 0.01, Student’s t-test). (F) MFGE8 and thioredoxin (TRX) expression in cell lysates (left) and secretomes (right), as analyzed by western blotting. GAPDH and Ponceau S were used as a loading control. (G) The secretion of TRX was determined by ELISA (n = 3, mean ± S.D., **P < 0.01, one-way ANOVA, least significant difference test).CC BY · PubMed Central
Figure 3 IC-2 increases the production and secretion of matrix metalloproteinases (MMPs) in mesenchymal stem cells (MSCs). (A) mRNA expression of fibrolytic genes in MSCs on day 7 in vitro (n = 3, mean ± S.D., **P < 0.01, Student’s t-test). (B) In vitro activities of MMP-1 and MMP-14 in MSCs on day 7 (n = 3, mean ± S.D., **P < 0.01, one-way ANOVA, Tukey test). (C) Expression of MMPs in the secretome of MSCs in vitro. (D) Images of liver tissue used in the experiments and enzymatic activities of MMPs in liver tissues containing cell sheets. Data are expressed as activity relative to that in the CCl4(−) group. CCl4(−) indicates control mice without CCl4 intoxication. Images of liver tissues used in these experiments (left). MMP activities (middle) and activities of total MMPs (right), consisting of active enzyme and latent pro-enzyme (n = 6, mean ± S.E.M., *P < 0.05, **P < 0.01, one-way ANOVA, Games–Howell test). (E) Linear regression analysis of relative activities of active MMP-1 (left) or active MMP-14 (right) with respect to hepatic hydroxyproline content 9 days after transplantation (n = 12, Pearson’s correlation coefficient).
Figure 3 IC-2 increases the production and secretion of matrix metalloproteinases (MMPs) in mesenchymal stem cells (MSCs). (A) mRNA expression of fibrolytic genes in MSCs on day 7 in vitro (n = 3, mean ± S.D., **P < 0.01, Student’s t-test). (B) In vitro activities of MMP-1 and MMP-14 in MSCs on day 7 (n = 3, mean ± S.D., **P < 0.01, one-way ANOVA, Tukey test). (C) Expression of MMPs in the secretome of MSCs in vitro. (D) Images of liver tissue used in the experiments and enzymatic activities of MMPs in liver tissues containing cell sheets. Data are expressed as activity relative to that in the CCl4(−) group. CCl4(−) indicates control mice without CCl4 intoxication. Images of liver tissues used in these experiments (left). MMP activities (middle) and activities of total MMPs (right), consisting of active enzyme and latent pro-enzyme (n = 6, mean ± S.E.M., *P < 0.05, **P < 0.01, one-way ANOVA, Games–Howell test). (E) Linear regression analysis of relative activities of active MMP-1 (left) or active MMP-14 (right) with respect to hepatic hydroxyproline content 9 days after transplantation (n = 12, Pearson’s correlation coefficient).CC BY · PubMed Central
Figure 4 MMP-14 plays an important role in the anti-fibrotic effect of IC-2 sheets. (A) Downregulation of MMP-1 or MMP-14 expression through small interfering RNA (siRNA) transfection in IC-2 sheets was confirmed by western blotting. (B) Micrographs of Azan (upper) and Sirius red (lower) staining on the sixth day after transplantation in liver tissues transplanted with IC-2 sheets in which transfection of si-MMP-1 and/or si-MMP-14 was performed. (C) Measurement of the extent of fibrosis based on Azan staining (left) and Sirius red staining (right) (n = 5–6 per group except for n = 4 for DKD and n = 3 for CCl4(−) group. DKD group and CCl4(−) group indicate double knock-down of MMP-1 and MMP-14 and control mice without CCl4 intoxication, respectively (mean ± S.E.M., **P < 0.01, one-way ANOVA, Games–Howell test).
Figure 4 MMP-14 plays an important role in the anti-fibrotic effect of IC-2 sheets. (A) Downregulation of MMP-1 or MMP-14 expression through small interfering RNA (siRNA) transfection in IC-2 sheets was confirmed by western blotting. (B) Micrographs of Azan (upper) and Sirius red (lower) staining on the sixth day after transplantation in liver tissues transplanted with IC-2 sheets in which transfection of si-MMP-1 and/or si-MMP-14 was performed. (C) Measurement of the extent of fibrosis based on Azan staining (left) and Sirius red staining (right) (n = 5–6 per group except for n = 4 for DKD and n = 3 for CCl4(−) group. DKD group and CCl4(−) group indicate double knock-down of MMP-1 and MMP-14 and control mice without CCl4 intoxication, respectively (mean ± S.E.M., **P < 0.01, one-way ANOVA, Games–Howell test).CC BY · PubMed Central
Figure 5 Comparison of the anti-fibrotic effects of IC-2 sheets between CD90+/CD271+ bone marrow-derived mononuclear cells (BM-MNCs) and adherent BM-MNCs. (A) Micrographs of IC-2 liver sections subjected to Azan staining (upper) and Sirius red staining (lower). (B) Measurement of fibrotic areas based on Azan and Sirius red staining (n = 9–10 except for n = 3 for CCl4(−) group. CCl4(−) indicates control mice without CCl4 intoxication; mean ± S.E.M., *P < 0.05, one-way ANOVA, least significant difference test). (C) Hydroxyproline contents in liver tissues (n = 9–10 except for n = 3 for CCl4(−) group, mean ± S.E.M., *P < 0.05, one-way ANOVA, least significant difference test). (D) MMP-14 activity in BM-MNCs on the eleventh day after IC-2 treatment in vitro (n = 3, mean ± S.D., *P < 0.05, student’s t-test).
Figure 5 Comparison of the anti-fibrotic effects of IC-2 sheets between CD90+/CD271+ bone marrow-derived mononuclear cells (BM-MNCs) and adherent BM-MNCs. (A) Micrographs of IC-2 liver sections subjected to Azan staining (upper) and Sirius red staining (lower). (B) Measurement of fibrotic areas based on Azan and Sirius red staining (n = 9–10 except for n = 3 for CCl4(−) group. CCl4(−) indicates control mice without CCl4 intoxication; mean ± S.E.M., *P < 0.05, one-way ANOVA, least significant difference test). (C) Hydroxyproline contents in liver tissues (n = 9–10 except for n = 3 for CCl4(−) group, mean ± S.E.M., *P < 0.05, one-way ANOVA, least significant difference test). (D) MMP-14 activity in BM-MNCs on the eleventh day after IC-2 treatment in vitro (n = 3, mean ± S.D., *P < 0.05, student’s t-test).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 53 references

Cited by

See all 29

Metadata

Authors
Itaba, N., Kono, Y., Watanabe, K., Yokobata, T., Oka, H., Osaki, M., Kakuta, H., Morimoto, M., & Shiota, G.
Affiliations
  • Tottori University (JP)
  • KanonCure Inc. (Japan) (JP)
  • Okayama University (JP)
Corresponding author
Shiota, Goshi
Venue
Scientific Reports
Published
2019-05-02
Volume
9
Issue
1
Pages
6841-6841
ISSN
2045-2322 (ISSN-L)
OpenAlex
W2943631274
Cited by
29
References
53
Citations by year
2026: 6 · 2025: 3 · 2024: 1 · 2023: 6 · 2022: 5 · 2021: 4 · 2020: 3 · 2019: 1
FWCI
1.79
Type
journal article
Language
en
Open access
Licence
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Tokyo Tech Research Repository (Tokyo Institute of Technology) (submittedVersion)
Funders
Ministry of Education, Culture, Sports, Science and Technology
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
  • Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
Keywords
liver fibrosis, mesenchymal stem cells, cell sheets, orthotopic transplantation, antifibrotic therapy, hepatic stellate cells, MMP-14, MMP-1, thioredoxin, CCl4-induced liver fibrosis, bone marrow-derived stem cells
MeSH terms
Animals, Bridged Bicyclo Compounds, Bone Marrow Cells, Enzyme Inhibitors, Hexachlorophene, Humans, Immunohistochemistry, Liver Cirrhosis, Mice, Inbred BALB C, Temperature, Matrix Metalloproteinase 1, Collagen Type I, Mice, Matrix Metalloproteinase 14, Chemical and Drug Induced Liver Injury, Mesenchymal Stem Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Reversal of established liver fibrosis by IC-2-engineered mesenchymal stem cell sheets. https://app.cochat.ai/papers/10.1038/s41598-019-43298-0
The paper
Itaba, N., Kono, Y., Watanabe, K., Yokobata, T., Oka, H., Osaki, M., Kakuta, H., Morimoto, M., & Shiota, G. (2019). Reversal of established liver fibrosis by IC-2-engineered mesenchymal stem cell sheets. Scientific Reports. https://doi.org/10.1038/s41598-019-43298-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.